Difference between revisions of "Template:Glutamate receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Medgirl131 |
||
| Line 83: | Line 83: | ||
* [[Talampanel]] | * [[Talampanel]] | ||
| − | | group2 = {{abbrlink| | + | | group2 = {{abbrlink|Kainate|Kainate receptor}} |
| list2 = | | list2 = | ||
| + | * '''Agonists:''' ''Glutamate/active site agonists:'' [[5-Bromowillardiine]] | ||
| + | * [[5-Iodowillardiine]] | ||
| + | * [[Acromelic acid|Acromelic acid (acromelate)]] | ||
| + | * [[AMPA]] | ||
| + | * [[ATPA]] | ||
| + | * [[Domoic acid]] | ||
| + | * [[Glutamate]] | ||
| + | * [[Ibotenic acid]] | ||
| + | * [[Kainic acid]] | ||
| + | * [[LY-339,434]] | ||
| + | * [[Proline]] | ||
| + | * [[Quisqualic acid]] | ||
| + | * [[SYM-2081]]; ''Positive allosteric modulators:'' [[Cyclothiazide]] | ||
| + | * [[Diazoxide]] | ||
| + | * [[Enflurane]] | ||
| + | * [[Halothane]] | ||
| + | * [[Isoflurane]] | ||
| + | |||
| + | * '''Antagonists:''' [[ACEA-1011]] | ||
| + | * [[CNQX]] | ||
| + | * [[Dasolampanel]] | ||
| + | * [[DNQX]] | ||
| + | * [[gamma-D-Glutamylaminomethylsulfonic acid|GAMS]] | ||
| + | * [[Kaitocephalin]] | ||
| + | * [[Kynurenic acid]] | ||
| + | * [[Licostinel|Licostinel (ACEA-1021)]] | ||
| + | * [[LY-382,884]] | ||
| + | * [[NBQX]] | ||
| + | * [[NS102]] | ||
| + | * [[Selurampanel]] | ||
| + | * [[Tezampanel]] | ||
| + | * [[Theanine]] | ||
| + | * [[Topiramate]] | ||
| + | * [[UBP-302]]; ''Negative allosteric modulators:'' [[Barbiturates]] (e.g., [[pentobarbital]], [[sodium thiopental]]) | ||
| + | * [[Enflurane]] | ||
| + | * [[Ethanol]] | ||
| + | * [[Evans blue]] | ||
| + | * [[NS-3763]] | ||
| + | * [[Pregnenolone sulfate]] | ||
| + | |||
| + | | group3 = {{abbrlink|NMDAR|N-Methyl-D-aspartate receptor}} | ||
| + | | list3 = | ||
* '''Agonists:''' ''Glutamate/active site agonists:'' [[2-Amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid|AMAA]] | * '''Agonists:''' ''Glutamate/active site agonists:'' [[2-Amino-2-(3-hydroxy-5-methylisoxazol-4-yl)acetic acid|AMAA]] | ||
* [[Aspartate]] | * [[Aspartate]] | ||
| Line 286: | Line 328: | ||
* [[Trichloroethylene]] | * [[Trichloroethylene]] | ||
* [[Xylene]] | * [[Xylene]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}} | }} | ||
Revision as of 09:25, 27 August 2017
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Glutamate receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Glutamate receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Glutamate receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.